}
  • Icon Everyone is informed that if any person demands money in the name of providing any kind of job in AIIMS Nagpur, then immediately inform the AIIMS Administration on no.07103-295590 about that person.Despite this public notice, if any person gives money in the name of getting any kind of job in AIIMS Nagpur, then it will be his own responsibility.
  • Icon Appointment bookings shall be made exclusively through the eVaidya app. AIIMS Nagpur does not endorse any third-party private application for appointment scheduling.

Radiation Oncology Research and Publication

Clinical Trials

Sr.No. Title of Project Clinical Trial No.

Name of Principle

Investigator

Amount Received

Sponsors Status of Project (Ongoing/ Completed) Publication (YES/NO)
1. ALK28/ENZ130-PER1_A Prospective, Randomized, Multicenter, Comparative, Double-blind, Parallel study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Immunogenicity of Biosimilar Pertuzumab (ENZENE) with Reference Pertuzumab (Perjeta®, Genentech Inc.,) in Previously Untreated Patients with HER2 Positive Metastatic Breast Cancer.   ALK28/ENZ130 Dr.Vandana Singh Kushwaha   Perjeta®, Genentech Inc   Closed
2. CINC280AIN01_A prospective, multicentre, Open-label, Phase IV, Interventional study to assess the safety and efficacy of Capmatinib in Indian patients with Mesenchymal-Epithelial Transition (MET) exon 14 skipping Mutation Positive Advanced Non-small cell Lung Cancer (NSCLC)  CINC280AIN01 Dr.Vandana Singh Kushwaha   Novarties Pharma AG, Basel, Switzerland Ongoing No
3.

C2A03266(CA-170-302) A Phase IIb/III, Randomised, Double-blind, Placebo-controlled, Multicentre, Study of CA- 170 in Combination with Chemotherapy in Patients with Stage IV Non-Squamous Non-Small Cell Lung Cancer  (ASIAD-3)

C2A03266(CA-170-302)

Dr.Vandana Singh Kushwaha       closed

 

  • Non Funded Project
Sr.No.

Title of Project

Proposal No. (IEC No.)

Name of Principle Investigator Collaboration with other institute (if any) Status of Project (Ongoing/ Completed) Publication (YES/NO)
1. Establishment of Hospital Based Cancer registry at AIIMS, Nagpur IEC/Pharmac/2024/1039 dated12/11/2024 Dr. Chaitali S.M. Waghmare  ICMR-NCRP

Ongoing

No
  • Undergraduates/Postgraduates/PhD Research: Please submit IEC and title of research.

 1.Incidence of Hypothyroidism in Head and Neck Cancer patients treated with Volumetric Modulated Arc Radiation Therapy (VMAT) in a tertiary care hospital – Dr. Bhuvashree Podali Under guidance of Dr. Biswajyoti Das

2. Randomized Control Trial comparing standard fractionation versus hypofractionated radical (chemo) radiotherapy in p16 positive Oropharyngeal carcinoma treated by VMAT Technique. Aswin Unni under guidance of Dr. Vandana Singh Kushwaha

  • Publications

Year

Particulars of Article (In Vancouver format)

Impact Factor of the Journal

2013

Chaitali Waghmare. Radiation burn – From mechanism to management. BURNS 2013;39(2):212-219.

2.901

2015

Waghmare CM. Successful pregnancy after chemotherapy and surgery for an anterior abdominal wall desmoids tumor. International Journal of Reproduction, Contraception, Obstetrics and Gynecology 2015;4(5):1657-1658.

0.1

2015

Waghmare CM. Bilateral internal mammary lymph nodes- Is ipsilateral internal mammary lymph node treatment sufficient. Journal of Cancer Therapy 2015;6:1273-1275.

0.444

2015

Kushwaha VS , Gupta S, Husain N, Khan H, Negi M, Jamal N, Ghatak A. “Gefitinib, Methotrexate and Methotrexate plus 5-Florouracil as palliative treatment in recurrent head and neck squamous cell carcinoma”. Cancer Biol Ther. 2015 Feb;16(2):346-351

4.71

2015

Kushwaha VS, Srivastava K, Husain N, Singh S. “Unusual case of Hodgkin lymphoma presenting as soft tissue mass with intracranial metastasis and review of literature”. Clin Cancer Investig J. 2015;4:419-21

0.406

2015

Gupta S, Khan H, Kushwaha VS, Husain N, Negi M, Ghatak A, Bhatt ML. “Impact of EGFR and p53 expressions on survival and quality of life in locally advanced oral squamous cell carcinoma patients treated with chemoradiation”. Cancer Biol Ther. 2015 Jul 15. doi:10.1080/15384047.2015.1070985.

4.71

2015

Abbas M, Kushwaha VS, Srivastava K, Banerjee M. “Glutathione S-Transferase Gene Polymorphisms and Treatment Outcome in Cervical Cancer Patients under Concomitant Chemoradiation”. PLoS One. 2015 Nov 16;10(11):e0142501. doi: 10.1371/journal.pone.0142501.

2.6

2016

Waghmare CM. Objective voice assessment in patients of early glottis cancer. Jr DMIMSU 2016;11(4):389-392.

0.23

2016

Gupta S, Kushwaha VS, Verma S, Khan H, Bhatt ML, Husain N, Negi MPS, Bhosale VV, Ghatak A.  Understanding molecular markers in recurrent oral squamous cell carcinoma treated with chemoradiation. Heliyon 2 (2016) e00206. doi: 10.1016/j.heliyon.2016.e00206.

3.6

2017

P R Zopate, C M Waghmare, B H Tirpude. Scenario of accidental burns in rural part of central India. Indian J Forensic Med Toxicol  2017;11(2);211-6.

0.24

2017

Waghmare CM. Prospective, longitudinal and quantitative analysis of pattern of voice quality in male patients of early stage vocal cord cancer treated with radical radiation therapy. Jr DMIMSU 2017;12(1):66-69.

4.6

2017

Waghmare CM. Management of an early stage carcinoma of the true vocal cord. Pravara Medical Review 2017;9(2):4-12

0.07

2017

Waghmare CM, Dwivedi S, Jain VS. Pattern of palliative radiotherapy delivered using telecobalt machine for different malignant sites. GJRA 2017 doi:10.15371/22778160;6(12):3-5.

 

2017

Singh SS, Bhatt MLB, Kushwaha VS, Singh A , Kumar R, Gupta R, Parmar D. Role of matrix metalloproteinase 13 gene expression in the evaluation of radiation response in oral squamous cell carcinoma. J Carcinog. 2017 19;16:2.

1.5

2017

Singh SS, Kumar R, Kushwaha VS, Bhatt MLB, Singh A, Mishra A, Ram H, Parmar D, Gupta R. Expression of radioresistant gene PEG10 in OSCC patients and its prognostic significance. Asian Pacific Journal of Cancer Prevention. 2017 ;18(6):1513-1518.

1.8

2018

Virkar M, Jain VS, Waghmare CW, et al. Chemotherapy induced radiation recall reaction: a case report. Pravara Medical Review 2018;10(3):19-21

 

2018

Abbas M, Kushwaha VS, Srivastava K, Raza ST, Banerjee M. Impact of GSTM1, GSTT1 and GSTP1 genes polymorphisms on clinical toxicities and response to concomitant chemoradiotherapy in cervical cancer. British Journal of Biomedical Science. 2018 Oct; 75(4):169-174.

12.71

2019

Waghmare CW. When an Indian lady physician suffers from tuberculosis for the third time. Eur J Pharm Med Res 2019;691):182-184.

 

2019

Jain VS, Kawale D, Jain SM, Waghmare CW, et al. Various addiction patterns, dietary habits, associated medical problems, and socioeconomic status in gastrointestinal malignancies: a prospective study in rural area of Maharashtra, India. J Can Res Ther 2019;15:104-107.

1.3

2019

Jain VS, Kushwah V, Waghmare CW, et al. High dose rate surface mold brachytherapy in a case of squamous cell carcinoma of lower eyelid: a case report from a rural cancer center of maharashtra. J Radiat Cancer Res 2019;10:124-127.

1.3

2019

Jain VS, Bahgat N, Waghmare CW, et al Hyperfractionated radiotherapy with concurrent chemothrapy in locally advanced head and neck cancer-an observational study. Med Res Chronicles 2019;6(6):316-324.

 

2019

Jain VS, Waghmare CW, Bhagat N, et al Quantification of total circulating cell-free DNA as a screening modality for cancer. Pravara Med Rev 2019;11(4):14-20.

 

2020

Waghmmare CW, Jain VS, Arya B, et al. Radically treated breast cancer patient’s perception about routine follo-up visit. Oncol J India 2020;4:124-127.

 

2020

Bakshi N, Jain VS, Waghmare CW, et al. Second new primary PNET of kidney in a trated case of carcinoma breast: a case report. J Clin Diag Res 2020;14(12):XD01-XD03.

 

2020

Bakshi N, Jain VS, Waghmare CW, et al. Dose difference to target volume and organs at risk with three-diamentional conformal radiation therapy versus intensity modulated radiation therapy in carcinoma left breast post mastectomy patient: a study from a rural cancer centre in India. Int J Dent Med Scien Res 2020;2(60:290-295.

 

2020

Kumar S, Kaundal V, Kushwaha VS, Verma S, Negi M, Gupta N. Challenges in Screening, Diagnosis and Management of Colorectal Cancers in Covid-19 Era. Acta Scientific Medical Sciences .4.11 (2020): 28-33

 

1.403

2020

Kumar S, Kaundal V, Sood S, Kushwaha VS, Verma S, Negi M, Gupta N. Challenges and Management in Gynaecological Cancers in Covid 19 Crises: An Institutional Experience. Acta Scientific Cancer Biology .4.12 (2020): 03-09.

1.183

2020

Dr. Biswajyoti, Identification of factors influencing delayed presentation of cancer patients. International Journal of Community Medicine and Public Health 2020 7(5):xxx-xxx

0.201

2020

Dr. Biswajyoti, Sacrum metastasis in carcinoma gall bladder: an unusual presentation. International Journal of Research in Medical Sciences 2020 8(5):1884-1886

0.091

2020

Dr. Biswajyoti, Second primary chondrosarcoma of the maxilla: a case report. International Journal of Otorhinolaryngology and Head and Neck Surgery 2020 6(9):1733-1736.

0.46

2020

Dr. Biswajyoti, Synchronous dual malignancy: a rare case report of carcinoma breast with carcinoma gall bladder. International Journal of Research in Medical Sciences 2020 8(11):4140-4143.

0.091

2020

Gothwal RS, Shantanu S, Pradeep NE, Shivangi A, Sandeep J, Daleep S. demographic distribution of various cancers in patients attending radiotherapy opd at teritiary care centre in north west india. Int J Cur Adv Res 2020;9(12):23517-20.

 

2021

Jain VS, Kushwaha V, Pemmaraju G, Jain SM, Waghmare CW, et al. Outcome of locally advanced cervical cancer patients treated by IMRT boost as a non-brachytherapy alternative. British J Biomed Res 2021;5(1):1409-20

2.3

2021

Waghmare CM, Pawar HJ, Jain VS, Arya B, Thakur PK, Nirmal P. Marathi translation and linguistic validation of n updated European Organization for Reasearch and Treatment of Cancer Quality of Life Module for Head and Neck.  South Asian J Cancer 2021;9(4):199-203.

0.8

2021

Waghmare CW, Jain VS, Dwivedi S, Arya B. Retrospective analysis of epidemiological factors, pattern of care and oncology treatment outcome in Human Immunodeficiency Virus-positive cancer patients. Pravara Med Rev 2021;13(2):36-41.

 

2021

Pradeep NE, Shantanu S, Vipul M, Gothwal RS, Jain S.A prospective study to compare the effect of single(8gy) vs multifraction (20gy/5#) radiotherapy in palliation of painful bone metastasis. Int J Curr Adv Res. 2021;10(5):24522-25.

 

2021

Gupta N, Negi M, S Kumar, Kushwaha VS, Kaundal V, Sood S, Verma S.Awareness of Basics of Radiation, Dose Levels of Imaging Procedures and Radiation Safety among the Nurses in an Academic Hospital in Himachal Pradesh, India: Results of a Cross Sectional Study. Acta Scientific Cancer Biology 5.4 (2021): 05-10.

1.183

2021

Chatakonda SS, Vishwanathan B, Narayanan GS, Kapurmath SV, Kushwaha VS*, Narayanan SS, Venugopal R. Comparison of Hyperfractionated Radiotherapy with Concomitant Chemotherapy and Conventional Chemoradiotherapy in Locally Advanced Head and Neck Cancer Treated with Volumetric Modulated Arc Technique (VMAT). Acta Scientific Cancer Biology. 5.5 (2021): 02-11.

1.183

2022

Waghmare CM, Aggarwal V, Kahrde AL, Jain VS, Thakur PK. Marathi translation, linguistic validation ad cross-cultural adaptation of SHI and VHI in patients of head and neck squamous cell cancer. Indian J Cancer 2022;59(1);87-94

1.24

2022

Mahawar M, Jain V, Waghmare CW, et al. Three Dimensional Conformal Radiotherapy with Bilateral Wedge Fields versus Field in Field Technique in Operated Cases of Head and Neck Cancer, a Study from Rural Cancer Center of Maharashtra, India. Int J Dent Med Scien Reas 2022;4(2):144-150.

 

2022

Ravichandran M, Jain V, Waghmare CW, et al. A comparative study to assess the disease outcome in cervical carcinoma in patients treated with EBRT and concurrent Cisplatin and sequential brachytherapy versus treatment with interdigitated brachytherapy. Int J Dent Med Scien Reas 2022;4(2):108-114.

 

2022

Waghmare CW. Why is the EORTC QLQ C30 (version 3.0) still the most widely used quality of life assessment tool in oncology? Cancer Res Stat Treat 2022;5:376-8

4.8

2022

Waghmare CM, Arya B, Dwivedi S, Pawar HJ, Ravichandran M, Jain VS. Oncology treatment outcome in HIV-positive cancer cervix patients: where we are and what we achieved? J Cancer Reas Ther 2022;18:1537-40.

1.33

2022

Jain VS, Virkar M, Sarje MB, Waghmare CW, et al. Concurrent chemotherapy with high dose rate brachytherapyafter treatment with chemoradiotherapy in cases of locally advanced carcinoma cervix: a study from rural area of Maharashtra, India. J Cancer Reas Ther 2022;18:1572-77.

1.33

2022

Shankarnarayanan S, Jain VS, Waghmare CW, et al. To study the treatment outcome in post-operative cervical cancer patients availing radiotherapy and /or chemotherapy at a Rural Hospital. Int J Dent Med Scien Reas 2022;4(6):520-27.

 

2022

Bawaskar R, Jain VS, Waghmare CW, et al. A study of TPF v/s TP as induction chemotherapy in locally advanced head and neck cancers. Int J Dent Med Scien Reas 2022;4(6):712-18.

 

2022

Thomas TV, Jain VS, Waghmare CW, et al. A study on treatment options and response evaluation, disease patterns and known risk factors in carcinoma oesophagus in a Rural Hospital. Int J Dent Med Scien Reas 2022;4(6):554-61.

 

2022

Abbas M, Kushwaha VS, Srivastava K, Banerjee M. Understanding Role of DNA Repair and Cytochrome p-450 Gene Polymorphisms in Cervical Cancer Patient Treated with Concomitant Chemoradiation. British Journal of Biomedical Science, 79, (2022).

4.6

2023

Aggarwal VV, Waghmare CM, Lolage SN, Pawar HJ, Ravichandran M, Bhanu A. Subjective and perceptive assessment of speech/voice and swallowing function before and after radiation therapy in patients of head-and-neck squamous cell cancer. J Can Res Ther 2023;19:S373-9.

1.33

2023

Waghmare CM, Pawar HJ, Deshpande NS, Karle RR, Angarkar NN, Thakur PK. Pretreatment hematological parameters as predictors of tumor granulocyte-colony-stimulating factor expression in patients of head-and-neck squamous cell carcinoma. J Can Res Ther 2023;19:657-63.

1.33

2023

Dr. Biswajyoti, Dysphagia-optimised intensity-modulated radiotherapy versus standard radiotherapy in patients with pharyngeal cancer. The Lancet Oncology 2023 24(10):e397

88.5

2023

Patidar K, Waghmare CW, Pawar HJ. Association between depressive symptoms and socioeconomic status in head and neck cancer patients attending rural tertiary health care center. J Cancer Reas Ther2023;19(7):1880-86.

1.33

2023

Ghogale KS, Naorem R, Waghmare CW.Multiple primary head and neck squamous cell cancer: Lessons learnt. J Cancer Reas Ther2023;19(suppl2):S658-63.

1.33

2023

Naorem R, Ghogale KS, Waghmare CW. Multiple malignant primary tumors (non‑head and neck): Contemplation needed J Cancer Reas Ther2023;19(suppl2):S752-57.

1.33

2023

Waghmare CM, Aggarwal VV, Bhanu A, Ravichandran M. Marathi translation, linguistic validation, and cross-cultural adaptation of M.D. Anderson dysphagia inventory in patients of head and neck squamous cell cancer. Indian J Cancer. 2023;60(2):199-205

1.24

2024

Waghmare, C M, Pawar H J, Bhalwar, Rajvir, Thakur, P K. Psychometric analysis of Marathi version of an updated European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Head and Neck Module (EORTC QLQ-H&N43). Indian J Cancer 2024; 61(1):180-92.

1.24

2024

Kushwaha VS*, Srivastava K, Kumar S, Barik SK. Accelerated Radiotherapy Alone Versus Chemoradiation in Locally Advanced Carcinoma Cervix: Long-Term Outcomes. Cureus. 2024 16(7):e65154.

1.2

2024

Arya B, Wahmare CM, Jain VS, et al. Serum 25-Hydroxy Vitamin-D levels in head and neck cancer chemoradiation therapy: Potential in cancer therapeutics. Indian J Cancer 2024;61:403-7.

1.24

2025

Waghmare CM, Pawar HJ, Bhalwar R. Quality of life bedore and after radiotherapy in head and neck cancer patients measured using an updated head-neck specific EORTC QLQ-H&N43 at a rural tertiary cancer care center. South Asian J Can 2025 ; 14(2)170-78.

0.8